Skip to content

Search

Showing results for "mental health aboriginal"

2024 Run for a Reason – Team The Kids

The HBF Run for a Reason is back and if you’re looking for a reason to take part in this year’s event, let it be child health research.

Major conference tackles FASD from the head and the heart

Hundreds of delegates from around Australia, Canada and New Zealand arrive in Perth this week to discuss the latest knowledge about fetal alcohol spectrum disorder (FASD) at the 2nd Australasian FASD Conference 2018.

UV and Vitamin D

Researchers at The Kids Research Institute Australia are continuing to hone in on the effects of ultraviolet radiation and vitamin D on the immune system.

Genome-wide association and large-scale follow up identifies 16 new loci influencing lung function

Pulmonary function measures reflect respiratory health and are used in the diagnosis of chronic obstructive pulmonary disease.

Clinical Epigenetics

Epigenomic research at The Kids explores the links between childhood disease and the molecular hallmarks of epigenetic control.

Exercising Safely with Type 1 Diabetes – Development of Clinical Guidelines

Our research focuses on what are the best ways for patients with Type 1 Diabetes to exercise safely. We aim to develop clinical guidelines that provide improved advice for patients and educate patients on how to prevent hypos during and after exercise.

Research Assistant Paediatric Anaesthesia

RA to support clinical paediatric anaesthesia research projects

Clinical Services Manager - Autism Early Intervention Centre

The newly created role of Clinical Services Manager will lay the groundwork for an exciting new early intervention centre for kids showing early signs of autism

An Analysis of the Gut Microbiota and Related Metabolites following PCSK9 Inhibition in Statin-Treated Patients with Elevated Levels of Lipoprotein(a)

Atherosclerotic cardiovascular disease (ASCVD) is a leading cause of global mortality, often associated with high blood levels of LDL cholesterol (LDL-c). Medications like statins and PCSK9 inhibitors, are used to manage LDL-c levels and reduce ASCVD risk. Recent findings connect the gut microbiota and its metabolites to ASCVD development.

Burden of drug-resistant tuberculosis among contacts of index cases: A protocol for a systematic review

People having close contact with drug-resistant tuberculosis (DR-TB) patients are at increased risk of contracting and developing the disease. However, no comprehensive review has been undertaken to estimate the burden of DR-TB among contacts of DR-TB patients. Therefore, the current systematic review will quantify the prevalence and incidence of DR-TB among contacts of DR-TB patients.